Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
6.53
-0.29 (-4.32%)
At close: Apr 28, 2026, 4:00 PM EDT
6.40
-0.13 (-1.99%)
After-hours: Apr 28, 2026, 7:11 PM EDT
Verrica Pharmaceuticals Employees
Verrica Pharmaceuticals had 76 employees as of December 31, 2025. The number of employees increased by 5 or 7.04% compared to the previous year.
Employees
76
Change (1Y)
5
Growth (1Y)
7.04%
Revenue / Employee
$468,118
Profits / Employee
-$235,342
Market Cap
112.18M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 174 |
| Cibus | 118 |
| Immunic | 92 |
| Pyxis Oncology | 56 |
| Vivani Medical | 42 |
| Aardvark Therapeutics | 40 |
| KALA BIO | 38 |
| Cardiff Oncology | 31 |
VRCA News
- 13 days ago - Verrica Pharmaceuticals Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 19 days ago - Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting - GlobeNewsWire
- 22 days ago - Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - VRCA Investors Have the Opportunity to Join Investigation of Verrica Pharmaceuticals Inc. with the Schall Law Firm - Business Wire
- 5 weeks ago - VRCA Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA - Business Wire
- 5 weeks ago - Verrica Pharmaceuticals Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA - Business Wire
- 6 weeks ago - Verrica Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire